 Connection
James Bridges to Lipids
This is a "connection" page, showing publications James Bridges has written about Lipids.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.142 |
|
|
|
-
O'Callaghan M, Tarling EJ, Bridges JP, Redente EF, Byrne AJ, Keane MP, McCarthy C. Reexamining the Role of Pulmonary Lipids in the Pathogenesis of Pulmonary Fibrosis. Am J Respir Cell Mol Biol. 2024 Oct; 71(4):407-419.
Score: 0.040
-
Lee E, Williams KJ, McCarthy C, Bridges JP, Redente EF, de Aguiar Vallim TQ, Barrington RA, Wang T, Tarling EJ. Alveolar macrophage lipid burden correlates with clinical improvement in patients with pulmonary alveolar proteinosis. J Lipid Res. 2024 02; 65(2):100496.
Score: 0.038
-
O'Callaghan M, Duignan J, Tarling EJ, Waters DK, McStay M, O'Carroll O, Bridges JP, Redente EF, Franciosi AN, McGrath EE, Butler MW, Dodd JD, Fabre A, Murphy DJ, Keane MP, McCarthy C. Analysis of tissue lipidomics and computed tomography pulmonary fat attenuation volume (CTPFAV ) in idiopathic pulmonary fibrosis. Respirology. 2023 11; 28(11):1043-1052.
Score: 0.037
-
McCarthy C, Lee E, Bridges JP, Sallese A, Suzuki T, Woods JC, Bartholmai BJ, Wang T, Chalk C, Carey BC, Arumugam P, Shima K, Tarling EJ, Trapnell BC. Statin as a novel pharmacotherapy of pulmonary alveolar proteinosis. Nat Commun. 2018 08 07; 9(1):3127.
Score: 0.026
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|